Follicular lymphoma: bispecific and PI3Kδ-targeted approaches
Follicular lymphoma: bispecific and PI3Kδ-targeted app
Follicular lymphoma: bispecific and PI3Kδ-targeted app
New approaches in relapsed and refractory DLBCL Pol
Chronic lymphocytic leukemia: moving towards new horiz
Further steps to improve efficacy and safety in acute
Active monotherapies and combinations in mantle cell l
Potential strategies to overcome relapsed and refracto
Preface – ASH 2022 © Lebens.Med Zentrum Bad Erlach
Real-world risk assessment, outcomes and adoptio
Promising novel approaches in various B-cell mal
ASH 2021 - Paolo Ghia Paolo Ghia highlights what